-
201
Public Innovation Policy in the Pharmaceutical Industry: the Cases of the EU and USA
Published 2017-04-01“…Purpose: the main purpose of this article was to study the modern tools of the public innovation policy in the global pharmaceutical industry (US and EU cases), which is one of the most knowledge-intensive sectors of the global economy. …”
Get full text
Article -
202
Nanoencapsulation of bioactive ingredients: trends in pharmaceutical industry and functional foods
Published 2019-11-01Get full text
Article -
203
An SQWRL-Based Method for Assessing Regulatory Compliance in the Pharmaceutical Industry
Published 2022-10-01Subjects: Get full text
Article -
204
Intellectual Capital and Financial Performance of Biotech Companies in the Pharmaceutical Industry
Published 2018-08-01“…Therefore, the applied tests confirm ECD as the most suitable indicator to appreciate the intellectual capital for the biotech companies in the pharmaceutical industry…”
Get full text
Article -
205
Implementation of process optimization to maximize line productivity in pharmaceutical industries
Published 2023-11-01Subjects: Get full text
Article -
206
Non clinical research at CENTIS supporting biotechnological and pharmaceutical industry
Published 2012-07-01Get full text
Article -
207
GPs’ perceptions of their relationship with the pharmaceutical industry: a qualitative study
Published 2021-10-01“…Background: The pharmaceutical industry invests heavily in promoting medications to physicians. …”
Get full text
Article -
208
Application of Lean methodologies in the reduction of setup times in the pharmaceutical industry
Published 2019-01-01Subjects: Get full text
Article -
209
DEVELOPMENT STRATEGIES OF PHARMACEUTICAL INDUSTRY IN ACCORDANCE WITH THE HEALTHCARE NEEDS IN RUSSIA
Published 2019-02-01“…In the article current state of the Russian pharmaceutical industry, the pharmaceutical market and import of medicines to Russia regarding their compliance to the purposes and tasks set in industry strategic documents of development, and also to requirements of health care of the country is analysed. …”
Get full text
Article -
210
FEATURES OF ACCOUNTING AND INDIRECT COSTS SHARING IN PRODUCTION IN THE PHARMACEUTICAL INDUSTRY
Published 2016-01-01“…The article describes particular qualities into the method of cost accounting of production in the pharmaceutical industry, sub-sector production of antibiotics and fluids in liquid form. …”
Get full text
Article -
211
Mussel Shells, a Valuable Calcium Resource for the Pharmaceutical Industry
Published 2021-12-01“…One of the solutions proposed by us is the capitalization of calcium from shells in the pharmaceutical industry. (3) Results: The toxicity of calcium levulinate synthesized from the mussel shells was evaluated by the method known in the scientific literature as the Constantinescu phytobiological method (using wheat kernels, <i>Triticum vulgare</i> Mill). …”
Get full text
Article -
212
Indo-Pak Trade: Apprehensions and Opportunities for Pharmaceutical Industry of Pakistan
Published 2012-12-01Subjects: Get full text
Article -
213
Study on the financial performance of companies operating in the pharmaceutical industry in romania
Published 2016-03-01“…The study aims at determining the financial performance of companies in the pharmaceutical industry between 2009 and 2014 by means of the indicator of the financial return rate, using multiple linear regressions as research method. …”
Get full text
Article -
214
Strategy of crisis management of the pharmaceutical industry in the Republic of Sakha (Yakutiya)
Published 2019-04-01Subjects: Get full text
Article -
215
Production line balancing in the pharmaceutical industry using Goal Programming
Published 2019-05-01“…However, doing this leads to an increase in the stations’ number, that is not favorable because it raises the costs associated with the stations, therefore it is necessary to define strategies that allow achieving a balance be-tween these requirements.Objective−In this article we propose the formulation of a model for the line balancing, using the technique of multi-objective goal programming, applied to the pharmaceutical industry in order to minimize the stations’ number, minimize cycle time and inventory in process.Methodology−Goal programming is used to address a line balance model, which considers at the same time the assignment of multiple stations to one op-eration and the assignment of multiple operations to one station.Results−A significant decrease in cycle time and idle time at minimum costs is achieved, and a comparison between the deterministic and stochastic models is presented.Conclusions−Through this implementation of the LINGO model, the compliance of the proposed restric-tions, the precedence of operations and the proper func-tioning of the model were validated through the optimal solutions obtained. …”
Get full text
Article -
216
CURRENT TRENDS AND PROSPECTS OF THE RUSSIAN PHARMACEUTICAL INDUSTRY AND THE FOREIGN EXPERIENCE
Published 2018-01-01“…Trade agreements and union tendencies (EAES) on the scale of Eurasia can play a larger role – Russia's advantage is the fact that the countries of the former USSR have very limited own pharmaceutical industry, whilst the demand for quality products there is growing.…”
Get full text
Article -
217
THE EFFECT OF TRAINING IN THE IMPROVEMENT OF EMPLOYEE EFFICIENCY IN PHARMACEUTICAL INDUSTRY AND AN APPLICATION
Published 2013-01-01Subjects: Get full text
Article -
218
A Qualitative Analysis of Organisational Commitment in an Algerian Pharmaceutical Industry
Published 2023-03-01“…Then, qualitative research following the socio-economic approach to management will be conducted in the Algerian pharmaceutical industry to grasp the complexity of the concept. …”
Get full text
Article -
219
The Challenge of International Sanctions against Iranian Radio-Pharmaceutical Industry
Published 2018-03-01“…The case study is radio-pharmaceutical industry in Iran during the international sanctions (2000-2013) and the aftermath. …”
Get full text
Article -
220
Mergers, Acquisitions and Firms’ Performance: Experience of Indian Pharmaceutical Industry
Published 2010-05-01Get full text
Article